Leukemia, Acute Myelogenous (AML)
2 clinical trials · Condition
◉ Watch Leukemia, Acute Myelogenous (AML)
| Record | Firm | Date |
|---|---|---|
| CAR-T Cells Combined With Peptide Specific Dendritic Cell in Relapsed/Refractory Leukemia/MDS (NCT03291444) | Zhujiang Hospital | 2018-05-05 |
| Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the Blood (NCT00923910) | National Cancer Institute (NCI) | 2008-02-22 |
Track Leukemia, Acute Myelogenous (AML) automatically
Every clearance here is in the API, with alerts when new ones post.